Enanta Pharma Earnings Analysis: Q4 Recap

Enanta Pharma ENTA released its Q4 earnings on Monday, November 25, 2024 at 04:01 PM.

Here's what's important from the earnings announcement.

Earnings

Enanta Pharma beat estimated earnings by 4.0%, reporting an EPS of $-1.36 versus an estimate of $-1.41.

Revenue was down $4.33 million from the same period last year.

Earnings History Overview

Last quarter the company beat on EPS by $0.38 which was followed by a 1.0% increase in the share price the next day.

Here's a look at Enanta Pharma's past performance:

Quarter Q3 2024 Q2 2024 Q1 2024 Q4 2023
EPS Estimate -1.45 -1.33 -1.19 -2
EPS Actual -1.07 -1.47 -1.58 -1.33
Revenue Estimate 17.18M 16.52M 21.28M 17.50M
Revenue Actual 17.97M 17.05M 18.00M 18.93M

To track all earnings releases for Enanta Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!